KIMBERLY MANHARD - 25 Jul 2022 Form 4 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role
EVP, Drug Development, Director
Signature
/s/ Lisa Peraza Attorney-in-fact for Kimberly Manhard
Issuer symbol
HRTX
Transactions as of
25 Jul 2022
Net transactions value
$0
Form type
4
Filing time
27 Jul 2022, 18:21:17 UTC
Previous filing
15 Jul 2022
Next filing
17 Oct 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HRTX Employee Stock Option (Right to Buy) Award $0 +165,961 $0.000000 165,961 25 Jul 2022 Common Stock 165,961 $3.17 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable in 8 equal quarterly installments beginning one quarter after the date of grant (07/25/2022).